Orion
34.57 EUR +0.26%Orion operates in the pharmaceutical industry. The company conducts research and development of human and veterinary drugs, where the main focus is on diseases that affect the nervous system, as well as oncology and respiratory diseases. Today, the company's products are found on a global level, with the largest presence in the Nordic region and the rest of Europe. The company's head office is located in Espoo.
Log in to see the recommendation and risk by Inderes
Analyst
Latest videos
Financial calendar
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Ilmarinen Mutual Pension Insurance Company | 3.7 % | 5.2 % |
Erkki Etola and companies | 2.0 % | 6.5 % |
Premium
This content is for our Premium customers only.
Insider Transactions
Insider | Date | Total value |
---|---|---|
Mikael Silvennoinen | 15.11.2023 | 27,034EUR |
Mikael Silvennoinen | 15.11.2023 | 72,313EUR |
Premium
This content is for our Premium customers only.
Forum updates
Income statement
2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | |
---|---|---|---|---|---|---|---|---|
Revenue | 1,078.1 | 1,041.1 | 1,340.6 | 1,189.6 | 1,372.4 | 1,437.5 | 1,568.7 | 1,696.1 |
growth-% | 2.6 % | -3.4 % | 28.8 % | -11.3 % | 15.4 % | 4.7 % | 9.1 % | 8.1 % |
EBITDA | 336.5 | 289.0 | 486.6 | 326.4 | 331.0 | 360.5 | 427.1 | 492.4 |
EBIT (adj.) | 280.1 | 243.3 | 439.6 | 274.9 | 281.0 | 309.1 | 376.5 | 441.0 |
EBIT | 280.1 | 243.3 | 439.6 | 274.9 | 281.0 | 309.1 | 376.5 | 441.0 |
Profit before taxes | 278.3 | 242.3 | 440.3 | 271.9 | 279.8 | 303.1 | 370.6 | 435.6 |
Net income | 219.9 | 193.8 | 349.5 | 216.8 | 221.0 | 239.5 | 292.8 | 344.1 |
EPS (adj.) | 1.57 | 1.38 | 2.49 | 1.54 | 1.57 | 1.70 | 2.08 | 2.45 |
growth-% | 9.9 % | -11.9 % | 80.3 % | -38.0 % | 1.9 % | 8.4 % | 22.3 % | 17.5 % |
Dividend | 1.50 | 1.50 | 1.60 | 1.62 | 1.65 | 1.70 | 1.75 | 1.80 |
Dividend ratio | 95.8 % | 108.7 % | 64.3 % | 105.0 % | 104.9 % | 99.7 % | 84.0 % | 73.5 % |
Login required
This content is only available for logged in users
Profitability and return on capital
2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | |
---|---|---|---|---|---|---|---|---|
EBITDA-% | 31.2 % | 27.8 % | 36.3 % | 27.4 % | 24.1 % | 25.1 % | 27.2 % | 29.0 % |
EBIT-% (adj.) | 26.0 % | 23.4 % | 32.8 % | 23.1 % | 20.5 % | 21.5 % | 24.0 % | 26.0 % |
EBIT-% | 26.0 % | 23.4 % | 32.8 % | 23.1 % | 20.5 % | 21.5 % | 24.0 % | 26.0 % |
ROE | 29.1 % | 26.8 % | 43.1 % | 24.1 % | 24.9 % | 27.0 % | 31.9 % | 34.6 % |
ROI | 34.4 % | 29.5 % | 45.6 % | 24.9 % | 24.7 % | 25.9 % | 30.8 % | 34.6 % |
Login required
This content is only available for logged in users
Valuation
2020 | 2021 | 2022 | 2023 | 2024e | 2025e | 2026e | 2027e | |
---|---|---|---|---|---|---|---|---|
Share price (EUR) | 37.53 | 36.52 | 51.24 | 39.27 | 34.57 | 34.57 | 34.57 | 34.57 |
Shares | 140.5 | 140.5 | 140.5 | 140.5 | 140.5 | 140.5 | 140.5 | 140.5 |
Market cap | 5,271.6 | 5,129.7 | 7,197.3 | 5,516.0 | 4,855.8 | 4,855.8 | 4,855.8 | 4,855.8 |
Enterprise value | 5,085.8 | 4,940.3 | 7,078.7 | 5,609.3 | 5,039.9 | 5,033.0 | 5,018.4 | 4,964.7 |
EV/S | 4.7 | 4.7 | 5.3 | 4.7 | 3.7 | 3.5 | 3.2 | 2.9 |
EV/EBITDA | 15.1 | 17.1 | 14.5 | 17.2 | 15.2 | 14.0 | 11.8 | 10.1 |
EV/EBIT (adj.) | 18.2 | 20.3 | 16.1 | 20.4 | 17.9 | 16.3 | 13.3 | 11.3 |
EV/EBIT | 18.2 | 20.3 | 16.1 | 20.4 | 17.9 | 16.3 | 13.3 | 11.3 |
P/E (adj.) | 24.0 | 26.5 | 20.6 | 25.4 | 22.0 | 20.3 | 16.6 | 14.1 |
P/E | 24.0 | 26.5 | 20.6 | 25.4 | 22.0 | 20.3 | 16.6 | 14.1 |
P/B | 7.2 | 7.2 | 7.9 | 6.2 | 5.5 | 5.4 | 5.1 | 4.7 |
P/S | 4.9 | 4.9 | 5.4 | 4.6 | 3.5 | 3.4 | 3.1 | 2.9 |
Dividend yield | 4.0 % | 4.1 % | 3.1 % | 4.1 % | 4.8 % | 4.9 % | 5.1 % | 5.2 % |
Equity ratio | 65.6 % | 66.0 % | 60.4 % | 61.9 % | 56.9 % | 56.9 % | 58.1 % | 61.6 % |
Gearing ratio | -25.4 % | -26.5 % | -13.1 % | 10.5 % | 20.8 % | 19.9 % | 17.2 % | 10.4 % |
Login required
This content is only available for logged in users
Quarter data
Q1/23 | Q2/23 | Q3/23 | Q4/23 | 2023 | Q1/24e | Q2/24e | Q3/24e | Q4/24e | |
---|---|---|---|---|---|---|---|---|---|
Revenue | 277.9 | 289.6 | 301.0 | 321.1 | 1,189.6 | 306.2 | 321.3 | 311.8 | 433.1 |
EBITDA | 67.7 | 59.4 | 92.7 | 106.6 | 326.4 | 64.6 | 67.1 | 65.5 | 133.8 |
EBIT | 55.5 | 46.6 | 79.9 | 92.9 | 274.9 | 52.1 | 54.6 | 53.0 | 121.3 |
Profit before taxes | 55.1 | 45.8 | 78.5 | 92.5 | 271.9 | 51.8 | 54.3 | 52.7 | 121.0 |
Net income | 43.8 | 36.4 | 61.4 | 75.2 | 216.8 | 40.9 | 42.9 | 41.6 | 95.6 |
Login required
This content is only available for logged in users
The change negotiations concerning Orion’s Kuopio plant have been concluded – the company has decided to continue to explore the outsourcing of production at the plant
Orion Corporation: Organising meeting of the Board of Directors
Join Inderes community
Don't miss out - create an account and get all the possible benefits